75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Description of the Business
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Investments
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Fair Value of Financial Instruments
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Goodwill
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Shareholders’ Equity
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Warrants
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Stock-based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Credit Facility
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Segment Reporting
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Investments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Fair Value of Financial Instruments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Goodwill and Intangible Assets, Net (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Accrued Expenses (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Shareholders’ Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Warrants (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Stock-based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Credit Facility (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Segment Reporting (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Description of the Business - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Basis of Ppresentation and Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share due to Anti-dilutive Effect (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Investments - Schedule of available-for-sale investments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Investments - Schedule of Maturities of Company's Investment (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Investments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Fair Value of Financial Instruments - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Fair Value of Financial Instruments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Fair Value of Financial Instruments - Schedule of Assumptions used to Determine Fair Value of 2022 USD Financing Warrants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Goodwill - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Accrued Expenses - Summary of Accrued Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Accrued Expenses - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Shareholders' Equity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Shareholders' Equity - Summary of Shares Reserved For Issuance (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Warrants - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Warrants - Summary of Outstanding Liability Classified as Warrants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Warrants - Summary of Activity of Outstanding Warrant Liability (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Stock-based Compensation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Stock-based compensation - Schedule of Fair Value Assumptions of Options (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Stock-based Compensation - Schedule of Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Stock-based Compensation - Schedule of Restricted Share Units (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Stock-based Compensation - Summary of Stock-based Compensation Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Credit Facility - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Credit Facility - Schedule of Future Expected Repayments of Principal Amount Due on Credit Facility (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Segment Reporting - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Segment Reporting - Summary of Additional Expense Details (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Subsequent Events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Weighted Average Number Of Diluted Common Shares Outstanding
Weighted average number of diluted common shares outstanding.
Weighted-average shares used in computing net loss per share attributable to common shareholders, diluted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Vested
Payment of deferred financing fees related to 2024 ATM
Payment Of Deferred Financing Fees Related To At-The-Market
Payment of deferred financing fees related to at-the-market.
Two Thousand Twenty Four At The Market Offering Program [Member]
Two Thousand Twenty Four At The Market Offering Program.
2024 At-The-Market Facilities
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Number of other than options, outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance
Debt Instrument, Convertible, If-converted Value in Excess of Principal
Debt instrument convertible, converted principal amount
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Accounts payable
Increase (Decrease) in Accounts Payable, Total
Increase (Decrease) in Accounts Payable
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Estimated Fair Value, Due in one year or less
Long-Term Debt, Excluding Current Maturities
Total credit facility, non-current, net
Total credit facility, non-current, net
Plan Name
Plan Name [Axis]
Research and Development Expense [Abstract]
Research and development:
Equity [Abstract]
Entity Current Reporting Status
Entity Current Reporting Status
Other commitment
Other Commitment, Total
Other Commitment
Proceeds from Warrant Exercises
Proceeds from exercise of 2022 USD Financing Warrants
Operating Expenses [Abstract]
Operating expenses:
Level 2
Fair Value, Inputs, Level 2 [Member]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Fair Value by Liability Class [Domain]
Document Fiscal Period Focus
Document Fiscal Period Focus
Entity Shell Company
Entity Shell Company
Other Accrued Liabilities, Current
Other accruals
Short-Term Investments [Member]
Short-term investments
Segment Reporting, Policy [Policy Text Block]
Segments
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Total
Cash and Cash Equivalent
Schedule of Future Expected Repayments of Principal Amount Due on Credit Facility
Schedule of Maturities of Long-Term Debt [Table Text Block]
Goodwill Disclosure [Text Block]
Goodwill
Common Stock, Shares, Issued, Total
Common Stock, Shares, Issued
Common stock, shares issued
Schedule of Directors' Deferred Share Unit Plan
Share-based Payment Arrangement, Directors' Deferred Share Unit Plan, Activity [Table Text Block]
Share-based payment arrangement, directors' deferred share unit plan, activity.
Asset Class [Domain]
Statement [Table]
Statement [Table]
Weighted average fair value of shares purchased upon exercise of warrants.
Weighted Average Fair Value Of Shares Purchased Upon Exercise Of Warrants
Weighted average fair value of shares purchased upon exercise of warrants
Debt Instrument Extended Maturity Date
Debt instrument extended maturity date.
Debt instrument extended maturity date
Statement [Line Items]
Statement [Line Items]
Weighted average exercise price, expired
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Entity Filer Category
Entity Filer Category
Selling, General and Administrative Expenses, Policy [Policy Text Block]
General and Administrative
Liabilities and Equity
Total liabilities and shareholders' equity
Payables and Accruals [Abstract]
K2 HealthVentures LLC.
K2 HealthVentures LLC [Member]
K2HV
Subordinate voting shares.
Subordinate Voting Shares [Member]
Subordinate Voting Shares
Cash equivalents
Cash and Cash Equivalents, Fair Value Disclosure
Shares Issued, Price Per Share
Shares issued, price per share
Subsequent Event [Line Items]
Converted into common shares
DebtInstrument Convertible Converted Into Common Shares
Debtinstrument convertible converted into common shares.
Goodwill
Goodwill
Goodwill, Ending Balance
Goodwill, Beginning Balance
Goodwill, Total
Stock Option
Debt repayments of principal in year two before unamortized debt issuance cost.
Debt Repayments of Principal in Year Two Before Unamortized Debt Issuance Cost
2027
Additional paid-in capital
Additional Paid in Capital, Common Stock, Ending Balance
Additional Paid in Capital, Common Stock, Beginning Balance
Measurement Input, Risk Free Interest Rate [Member]
Risk-free rate
Intangible assets, useful life
Intangible assets, Useful Lives (in years)
Intangible assets (acquired technology), Useful life
Vesting [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of options, granted
Schedule of Computation of Basic and Diluted Net Loss Per Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Underwritten offering.
Underwritten Offering [Member]
Underwritten Offering
2026 Underwritten Offering
Options Issued and Outstanding Under Stock Option Plan
Options Issued and Outstanding Under Stock Option Plan [Member]
Options issued and outstanding under stock option plan.
Investments Classified by Contractual Maturity Date [Table Text Block]
Schedule of Maturities of Company's Investment
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Basic
Net loss per common share, basic
Debt Securities, Available-for-Sale, Premium on Purchased Options [Policy Text Block]
Short-Term Investments
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Loss on foreign currency translation
Number of options, outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Number of options, outstanding
Common shares subject to outstanding option awards
Number of shares
Conversion of 2022 USD Financing Warrants to common shares upon exercise of warrants
Stock Issued
Total current liabilities
Liabilities, Current
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Directors' Deferred Share Unit Liability
DDSU Liability
Directors' deferred share units liability.
Withholding Taxes Payable on Option Exercises
Withholding taxes payable on option exercises.
Withholding taxes payable on option exercises
Accounting Standards Update [Axis]
Equity, Attributable to Parent [Abstract]
Shareholders' Equity:
Entity Small Business
Entity Small Business
Accrued expenses
Increase (Decrease) in Accrued Liabilities, Total
Increase (Decrease) in Accrued Liabilities
Debt repayments of principal in year three before unamortized debt issuance costs.
Debt Repayments of Principal in Year Three Before Unamortized Debt Issuance Costs
2028
Retained Earnings (Accumulated Deficit), Ending Balance
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Total
Retained Earnings (Accumulated Deficit)
Accumulated deficit
ASU 2016-02
Accounting Standards Update 2016-02 [Member]
Description of the Business
Nature of Operations [Text Block]
Number of options, forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Proceeds from Issuance Initial Public Offering
Proceeds from equity offerings
Sale of Stock, Price Per Share
Share issued price per share
Measurement input
Warrants and Rights Outstanding, Measurement Input
Share-Based Payment Arrangement [Text Block]
Stock-based Compensation
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Stock issued during period shares warrants exercised.
Stock Issued During Period Shares Warrants Exercised
Exercise of Warrants, Shares
Weighted Average Number of Shares Outstanding, Diluted, Adjustment
Weighted Average Number of Shares Outstanding, Diluted, Adjustment, Total
Incremental shares from 2022 USD Financing Warrants
Weighted average grant date fair value, cancelled
Weighted average grant date fair value, cancelled
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period, Weighted Average Grant Date Fair Value
Share-based compensation arrangement by share-based payment award, equity instruments other than options, cancelled in period, weighted average grant date fair value.
Amendment Flag
Amendment Flag
Earnings Per Share, Policy [Policy Text Block]
Net Loss Per Share
Liabilities and Equity [Abstract]
Liabilities and Shareholders’ Equity
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operating activities
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Common Stock [Member]
Common Stock
Accounting Standards Update and Change in Accounting Principle [Table]
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted average exercise price, issued
Weighted average exercise price, granted
Debt Securities, Available-for-Sale [Line Items]
Debt Instrument, Interest Rate, Effective Percentage
Debt instrument interest rate
Entity Address, Address Line One
Entity Address, Address Line One
Change in accounting principle, accounting standards update, immaterial effect [true false]
Fair value of assets transfers out of Level 3
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of Fair Value Assumptions of Options
Marketable Securities [Table]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
Amortized Cost, Total
Income Tax, Policy [Policy Text Block]
Income Taxes
Bought deal financing.
Bought Deal Financing [Member]
Bought Deal Financing
Supplemental Cash Flow Information
Supplemental Cash Flow Information [Abstract]
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign Currency
Class of Warrant or Right [Axis]
Class of Warrant or Right
Document Type
Document Type
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
2022 USD Financing Warrant Liability
Two Thousand Twenty Two USD Financing Warrant Liability [Member]
Two thousand twenty two usd financing warrant liability.
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative
Entity Central Index Key
Entity Central Index Key
Two Thousand Twenty Five Equity Incentive Plan [Member]
Two thousand twenty five equity incentive plan.
2025 Equity Incentive Plan
Line of Credit Facility [Table]
Debt Securities, Available-for-Sale [Table Text Block]
Schedule of available-for-sale investments
Investments, Debt and Equity Securities [Abstract]
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net increase/(decrease) in cash and cash equivalents
Subsequent Event Type [Domain]
Change in fair value of 2022 USD Financing Warrants
Change in fair value of 2022 USD Financing Warrants
Change in fair value of the warrant liability
Fair Value Adjustment of Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive securities excluded from computation of loss per share
Common Stock, Par or Stated Value Per Share
Common stock, par value
Accounting Standards Update [Domain]
Tranche One
Share-Based Payment Arrangement, Tranche One [Member]
Amortization Of Deferred Financing Costs
Amortization of deferred financing costs.
Amortization of deferred financing costs
Weighted average remaining contractual life (Years), outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Expected volatility, maximum
Amortized Cost
Debt Securities, Available-for-Sale, Amortized Cost
Debt Securities, Available-for-Sale, Amortized Cost, Total
Accrued compensation
Workers' Compensation Liability, Current
Estimated Fair Value
Debt Securities Available-for-sale
Debt Securities, Available-for-Sale
Debt Securities, Available-for-Sale, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Number of options, exercised
Exercise of stock options, net of shares withheld for exercise and tax, Shares
Debt Disclosure [Abstract]
Accrued Liabilities, Current
Accrued expenses
Total accrued expenses
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock Issued During Period Shares Conversion Of Term Loan Principal
Stock issued during period shares conversion of term loan principal.
Issuance of common shares upon conversion of term loan principal, Shares
Current Fiscal Year End Date
Current Fiscal Year End Date
Aggregate number of common shares owned by holder percentage
Aggregate Number Of Common Shares Owned By Holder Percentage
Aggregate number of common shares owned by holder percentage.
Document Quarterly Report
Document Quarterly Report
Fair Value, by Balance Sheet Grouping [Table]
Fair Value By Balance Sheet Grouping [Table]
Entity Address, State or Province
Entity Address, State or Province
Number of shares, beginning balance
Number of shares, ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Financial liabilities
Financial liabilities
DDSU Liability
Balance at December 31, 2025
Balance at June 30, 2026
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive loss
Net loss and comprehensive loss
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Unrealized Gain
Research and Development Expense, Policy [Policy Text Block]
Research and Development
Total shares reserved for issuance
Common Shares reserved for issuance
Common shares reserved for future issuance
Subordinate Voting Shares
Subordinate voting.
Subordinate Voting [Member]
Subordinate Voting
Class of Warrant or Right [Domain]
Class of Warrant or Right
Line of Credit Facility, Lender [Domain]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Summary of Stock-based Compensation Expense
Stock Issued During Period, Value, Stock Options Exercised
Exercise of stock options, net of shares withheld for exercise and tax
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
Accrued Expenses
Amortization of deferred ATM costs
Adjustments to Additional Paid in Capital, Amortization of deferred ATM costs
Adjustments to Additional Paid in Capital, Amortization of deferred ATM costs
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive loss
Performance Shares [Member]
Performance shares units
Underwritten Public Offering
Underwritten Public Offering [Member]
Underwritten public offering Member
Subsequent Event [Member]
Subsequent Event
Increase (Decrease) in Director's Deferred Share Unit-related Accruals
Increase (decrease) in director’s deferred share unit-related accruals.
Increase in director's deferred share unit-related accruals
Unvested RSUs
Unvested Restricted Stock Units (RSUs) [Member]
Unvested restricted stock units (RSUs).
Exercise of Warrant shares.
Warrants exercised
Exercise of Warrant shares
Other non-current assets
Other Assets, Noncurrent
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Unamortized debt issuance costs
Expected life
Measurement Input, Expected Term [Member]
Antidilutive Securities [Axis]
Weighted-average shares used in computing net loss per share attributable to common shareholders, basic
Weighted Average Number Of Common Shares Outstanding Basic
Weighted average number of common shares outstanding basic.
Number of options, expired
Number of options, expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Vesting percentage
Basis of Presentation and Summary of Significant Accounting Policies
Interest Expense, Debt, Total
Interest Expense, Debt
Interest expense
Indication of impairment of goodwill and long-lived assets.
Indication of Impairment of Goodwill and Long-lived Assets
Indication of impairment of goodwill and long-lived assets
AOCI Attributable to Parent [Member]
Accumulated OCI
Goodwill, Impairment Loss
Impairment charges of goodwill
Debt Instrument, Convertible, Beneficial Conversion Feature
Debt instrument convertible, conversion feature principal
Debt Instrument, Maturity Date
Debt instrument, maturity date
Line of Credit Facility, Fair Value of Amount Outstanding
Fair value of credit facility
Minimum [Member]
Minimum
Weighted average grant date fair value, granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Financial Instrument [Axis]
Assets, Current [Abstract]
Current assets:
Shares Available for Grant Under Stock Option Plan
Shares Available for Grant Under Stock Option Plan [Member]
Shares available for grant under stock option plan.
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Number of shares purchasable for each warrant
Other non-cash adjustments.
Other Non Cash Adjustments
Other non-cash adjustments
Amortization of intangible assets
Amortization of Intangible Assets
Amortization of Intangible Assets, Total
Fair Value, Inputs, Level 3 [Member]
Level 3
Proceeds from Long-Term Lines of Credit
Proceeds from credit facility
Segment Reporting [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Business Combination [Policy Text Block]
Business Combinations
Unrealized Gain (Loss) on Investments
Unrealized gain/(loss) on investments
Current liabilities:
Liabilities, Current [Abstract]
Shares, Outstanding
Balance, Shares
Balance, Shares
Commitments and Contingencies
Commitments and contingencies (Note 10)
CAD financing and compensation warrants.
CAD Financing And Compensation Warrants [Member]
CAD financing and Compensation Warrants
Debt repayments of principal, remainder of fiscal year, before unamortized debt issuance cost.
Debt Repayments Of Principal Remainder Of Fiscal Year Before Unamortized Debt Issuance Cost
Remainder of 2026
Weighted average grant date fair value, ending balance
Weighted average grant date fair value, beginning balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
General and Administrative Expense [Member]
General and Administrative
Debt Instrument, Basis Spread on Variable Rate
Term Loan bears a variable interest rate
Reverse stock split description
Stockholders' Equity, Reverse Stock Split
Common stock, no par value
Common Stock, No Par Value
Available For Sale Securities Debt Maturities After Two Through Three Years Fair Value
Available for sale securities debt maturities after two through three years fair value.
Estimated Fair Value, Due in two to three years
Equity Offering Costs in Prepaids and Other Current Assets, Net
Equity offering costs in prepaids and other current assets, net.
Equity offering costs in prepaids and other current assets, net
Effect of exchange rate changes on cash
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Class of warrant or right number of securities called by each unit.
Class Of Warrant Or Right Number Of Securities Called By Each Unit
Number of shares purchasable for each unit
USD Financing Warrants Not Included
USD Financing Warrants Not Included [Member]
USD Financing Warrants Not Included [Member]
Weighted Average Number of Shares Outstanding, Basic
Weighted-average common shares, basic
Total weighted-average shares used in computing net loss per share attributable to common shareholders, basic
Goodwill, Acquired During Period
Goodwill acquired during period
Weighted Average Number Of Diluted Pre Funded Warrants Outstanding
Weighted average number of diluted pre funded warrants outstanding.
Weighted-average pre-funded warrants used in computing net loss per share attributable to common shareholders, diluted
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Other liabilities, long-term
Other Liabilities, Long-Term
Other liabilities, long-term.
Proceeds from Issuance of Private Placement
Net proceeds from private placement
Subsequent Events
Subsequent Events [Text Block]
Recognized of incremental compensation cost
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Stock-based compensation expense
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]
Estimated Fair Value
Equity, Attributable to Parent
Balance
Balance
Total shareholders' equity
Payments to Acquire Investments, Total
Payments to Acquire Investments
Purchases of investments
Purchases of investments
Increase (Decrease) in Accrued Expenses Including Accrued Compensation and Accrued Clinical Trial Costs
Increase (decrease) in accrued expenses including accrued compensation and accrued clinical trial costs.
Increase in accrued expenses including accrued compensation and accrued clinical trial costs
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
Statement of Stockholders' Equity [Abstract]
Accrued Other Research and Development Costs Current
Accrued other research and development costs current.
Accrued other research and development costs
Share-Based Payment Arrangement, Tranche Two [Member]
Tranche Two
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Over-Allotment Option
Over-Allotment Option [Member]
Foreign exchange
Realized and unrealized gains and losses from foreign exchange
Foreign Currency Transaction Gain (Loss), before Tax, Total
Gain (Loss), Foreign Currency Transaction, before Tax
Foreign exchange loss, net
Entity Address, Address Line Two
Entity Address, Address Line Two
Fair Value of Financial Instruments
Fair Value Disclosures [Text Block]
Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
Available for sale securities debt maturities after one through two years fair value.
Estimated Fair Value, Due in one to two years
Warrants and Rights Note Disclosure [Abstract]
Entity Incorporation, Date of Incorporation
Entity date of incorporation
Schedule of Accrued Liabilities [Table Text Block]
Summary of Accrued Expenses
Debt Instrument, Name [Domain]
Debt Instrument, Name
Noncash Investing and Financing Items [Abstract]
Supplemental Noncash Disclosures
Number of shares, cancelled
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period
Share-based compensation arrangement by share-based payment award, equity instruments other than options, cancelled in period.
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Plan Name [Domain]
Plan Name
Interest Expense, Total
Interest expense
Interest Expense, Operating and Nonoperating
Credit Facility [Axis]
Multiple voting.
Multiple Voting [Member]
Multiple Voting
Weighted average exercise price, vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights
Vesting rights, description
Schedule Of Warrant Liability [Table Text Block]
Schedule of warrant liability.
Summary of Activity of Outstanding Warrant Liability
Class of Warrant or Right, Outstanding
Balance at December 31, 2025
Balance at June 30, 2026
Class of Warrant or Right [Table]
Class Of Warrant Or Right [Table]
Fair value of liabilities transfers into Level 3
First tranche term loan.
First Tranche Term Loan [Member]
First Tranche Term Loan
Long Term Investments.
Long-term investments
Long Term Investments [Member]
Entity Address, City or Town
Entity Address, City or Town
PRSU Plan
Performance And Restricted Share Unit Plan [Member]
Performance And Restricted Share Unit Plan Member.
Number of reportable segment
Number of Reportable Segments
Security Exchange Name
Security Exchange Name
Credit Facility [Domain]
Sale of equity, remaining offering amount.
Sale Of Equity Remaining Offering Amount
Sale of securities remaining availablility
Long-Term Debt, Gross
Total principal repayments
Entity Bankruptcy Proceedings, Reporting Current
Entity Bankruptcy Proceedings, Reporting Current
Measurement Input Type [Domain]
Antidilutive Securities, Name [Domain]
Issuance Of Common Shares Upon Conversion Of Term Loan Principal
Issuance of common shares upon conversion of term loan principal.
Issuance of common shares upon conversion of term loan principal
Warrants
Warrants disclosure.
Warrants Disclosure [Text Block]
Interest Paid, Excluding Capitalized Interest, Operating Activity
Cash paid for interest and final payment for credit facility
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Statistical Measurement [Domain]
Statistical Measurement
Common shares at an initial excercise price
Ending balance, weighted average exercise price
Beginning balance, weighted average exercise price
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrant exercise price
Assets, Current
Total current assets
Stock-based compensation
Total share-based compensation expense
Stock-based compensation expense recognized
Document Period End Date
Document Period End Date
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV
Proceeds from exercise of pre-funded warrants
Proceeds From Exercise Of Pre-funded Warrants
Proceeds from e xercise of pre-funded warrants
Financing warrants.
Financing Warrants [Member]
Financing Warrants
Statement of Financial Position [Abstract]
RSUs
Restricted Stock Units (RSUs) [Member]
Antidilutive Security, Excluded EPS Calculation [Table]
Vesting [Axis]
Class of Stock [Axis]
Class of Stock
Warrants and Rights Outstanding, Maturity Date
Warrants expiration date
Underwritten Offering Excluding Discounts and Commissions [Member]
Underwritten offering excluding discounts and commissions.
Underwritten Offering Excluding Discounts and Commissions
Total liabilities
Liabilities
Transaction Costs.
Transaction costs
Transaction Costs
Financial Instruments [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period
Requisite service period
Weighted Average Number of Shares Outstanding, Diluted
Weighted-average common shares, diluted
Total weighted-average shares used in computing net loss per share attributable to common shareholders, diluted
Stock Issued During Period Shares Upon Settlement Of Restricted Stock Unit Awards
Stock Issued During Period Shares Upon Settlement Of Restricted Stock Unit Awards.
Issuance of common shares upon settlement of restricted share unit ("RSU") awards, Shares
Entity File Number
Entity File Number
Cover [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Expected volatility, minimum
Measurement Input Type [Axis]
Warrants policy.
Warrants [Policy Text Block]
Warrants
Prepaid Expense and Other Assets, Current
Prepaid and other current assets
Fair value of liabilities transfers out of Level 3
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax
Unrealized foreign exchange
Sale of Stock [Domain]
Sale of stock, number of additional shares issued in transaction.
Sale of Stock, Number Of Additional Shares Issued in Transaction
Public offering, additional shares issued (in shares)
Segment Reporting
Segment Reporting Disclosure [Text Block]
General and Administrative Expense
Total
General and administrative
Subsequent Event [Table]
Sale of securities aggregate public offering price
Sale Of Equity Aggregate Public Offering Amount
Sale Of equity aggregate public offering amount.
Private placement shares
Stock Issued During Period, Shares, Other
Debt Instrument, Convertible, Conversion Price
Conversion price per share
Gain on extinguishment of contribution payable
Gain (Loss) on Extinguishment of Debt
Gain (Loss) on Extinguishment of Debt, Total
Gain on extinguishment of contribution payable
Stock issued during period value warrants exercised.
Stock Issued During Period Value Warrants Exercised
Exercise of Warrants
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Vesting period
Financial Liabilities Fair Value Disclosure [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Risk-free rate, minimum
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Unrecognized tax benefits, interest charges or penalties
Long-Term Investments, Total
Long-term investments
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Research and Development Internal Expense
Research and development internal expense.
Internal expenses
Document Transition Report
Document Transition Report
Internal expenses
General and Administrative Internal Expense
General and administrative internal expense .
Short-Term Investments, Total
Short-term investments
Operating Expenses
Total operating expenses
Research and Development Expense
Total
Research and development
Statement of Cash Flows [Abstract]
Debt repayments of principal in year four before unamortized debt issuance costs.
Debt Repayments of Principal in Year Four Before Unamortized Debt Issuance Costs
2029
Stock Issued During Period, Value, New Issues
Issuance of common shares, net of shares issuance cost
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Schedule of Stock Option Activity
Financial Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure [Abstract]
Equity [Text Block]
Shareholders’ Equity
2022 USD Financing Warrants
Financing Warrants Liability
Financing warrants liability.
Schedule of Restricted Share Units
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Exercised, shares
Warrants Exercised
Warrants exercised.
Net loss
Net loss attributable to common shareholders
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate intrinsic value, outstanding
Aggregate intrinsic value, outstanding
Aggregate Inducement Awards Outstanding
Aggregate inducement awards outstanding.
Aggregate inducement awards outstanding
Percentage of gross proceeds from sales of common shares payable as sales agent commission rate
Percentage Of Gross Proceeds Sale Of Common Shares Payable As Sales Agents Commission Rate
Percentage of gross proceeds sale of common shares payable as sales agents commission rate.
Expected life
Warrants and Rights Outstanding, Term
Expected dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Expected dividend yield
Weighted-average pre-funded warrants used in computing net loss per share attributable to common shareholders, basic
Weighted Average Number Of Pre Funded Warrants Outstanding Basic
Weighted average number of pre funded warrants outstanding basic.
Research and Development External Expense
Research and development external expense.
External expenses
Line of Credit Facility [Line Items]
Inducement Equity Awards [Member]
inducement equity awards member.
Inducement Equity Awards
Aggregate intrinsic value, vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Aggregate intrinsic value, vested and exercisable
Assets [Abstract]
Assets
Lease Liabilities Arising from Obtaining Right-Of-Use Assets
Lease liabilities arising from obtaining right-of-use assets.
Lease liabilities arising from obtaining right-of-use assets
Increase (Decrease) in Prepaid Expense and Other Assets, Total
Increase (Decrease) in Prepaid Expense and Other Assets
Prepaid and other current assets
Document Fiscal Year Focus
Document Fiscal Year Focus
Cash flows from investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
2022 USD Financing Warrants
2022 USD Financing Warrants.
2022 USD Financing Warrants [Member]
Accounts Payable, Current, Total
Accounts Payable, Current
Accounts payable
Research and Development Expense [Member]
Research and Development
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Investments
ASU 2019-12
Accounting Standards Update 2019-12 [Member]
Other noncurrent assets
Increase (Decrease) in Other Noncurrent Assets
Fair Value Measurement, Policy [Policy Text Block]
Fair Value Measurements
Proceeds from Stock Options Exercised
Proceeds from exercise of options
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
External expenses
General and Administrative External Expense
General and administrative external expense.
Share price
Measurement Input, Share Price [Member]
Net Income (Loss) Available to Common Stockholders, Basic
Net Income (Loss) Available to Common Stockholders, Basic, Total
Net loss attributable to common shareholders, basic
Long-Term Line of Credit
Long-Term Line of Credit, Total
Line of Credit
Debt Instrument [Axis]
Debt Instrument
Share-Based Payment Arrangement [Abstract]
Assets, Fair Value Disclosure
Assets, Fair Value Disclosure, Total
Financial assets
Sale of Stock [Axis]
Proceeds from issuance of common shares under ESPP
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash used in investing activities
Private Placement [Member]
Private Placement
Fair value of assets transfers into Level 3
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3
Title of 12(b) Security
Title of 12(b) Security
Schedule of Segment Reporting Information, by Segment [Table]
Weighted average exercise price, forfeited
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Vested and Unissued RSUs
Vested and Unissued Restricted Stock Units (RSUs) [Member]
Vested and unissued restricted stock units (RSUs).
Class of Warrant or Right [Line Items]
Class Of Warrant Or Right [Line Items]
Summary of Shares Reserved for Issuance
Summary of shares reserved for issuance.
Summary of Shares Reserved For Issuance [Table Text Block]
Restructured Agreement
Restructured Agreement [Member]
Restructured Agreement
Other non-current liabilities
Other Liabilities, Noncurrent
Common Share and Warrant Public Offering
Common Share and Warrant Public Offering [Member]
Common Share and Warrant Public Offering Member.
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted average exercise price, outstanding
Weighted average exercise price, outstanding
Additional Paid-in Capital [Member]
Additional Paid-In Capital
Covenant shall be waived during market capitalization exceeds
Covenant Shall be Waived During Market Capitalization Exceeds
Covenant shall be waived during market capitalization exceeds.
Measurement Frequency [Domain]
Measurement Frequency
Statement of Income Location, Balance [Axis]
Income Statement Location
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in accounting principle, accounting standards update, adoption date
Trading Symbol
Trading Symbol
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Risk-free rate, maximum
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Amortized Cost, Due in one year or less
Subsequent Event Type [Axis]
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Summary of Carrying Value of Intangible Assets
Summary of Intangible Assets
Cash flows from financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Expected term
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Expected life
Recurring
Fair Value, Recurring [Member]
Entity Ex Transition Period
Entity Ex Transition Period
Increase (Decrease) in Accrued Payroll Taxes
Increase (decrease) in accrued payroll taxes.
Increase in accrued payroll taxes
Warrants, Valuation Technique [Extensible Enumeration]
Warrants and Rights Outstanding, Valuation Technique [Extensible Enumeration]
ASU 2016-13
Accounting Standards Update 2016-13 [Member]
Warrants issued.
Warrants Issued
Warrants issued
Issued, shares
Equity Components [Axis]
Equity Components
Weighted average remaining contractual life (Years), vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Equity Component [Domain]
Equity Component
Asset Class [Axis]
Goodwill and Intangible Assets Disclosure [Abstract]
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Nominal amount of expense in relation to ESPP
Issuance of common shares under employee share purchase plan ("ESPP"), Shares
Investment Income, Interest and Dividend, Total
Investment Income, Interest and Dividend
Interest income
Debt repayments of principal in next twelve months before unamortized debt issuance cost.
Debt Repayments of Principal in Next Twelve Months Before Unamortized Debt Issuance Cost
2026
Directors' Deferred Share Unit Plan
Directors' Deferred Share Unit Plan [Member]
Maximum
Maximum
Statistical Measurement [Axis]
Statistical Measurement
Amendment Term Loans [Member]
Amendment term loans.
Amendment Term Loans
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Weighted average exercise price, exercised
Weighted average market price of options exercised
Common Stock, Value, Issued, Ending Balance
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Total
Common Stock, Value, Issued
Common shares, no par value, unlimited authorized as of June 30, 2026 and December 31, 2025; 134,365,950 and 98,776,265 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Net Income (Loss) Available to Common Stockholders, Diluted
Net Income (Loss) Available to Common Stockholders, Diluted, Total
Net loss attributable to common shareholders, diluted
Compensation warrants.
Compensation Warrants [Member]
Compensation Warrants
Common share and warrant public offering expire date
Common Share and Warrant Public Offering Expire Date
Common share and warrant public offering expire date.
Restricted Share Unit Awards And Performance Share Unit Awards [Member]
Restricted share unit awards and performance share unit awards.
Restricted Share Unit Awards and Performance Share Unit Awards
2026 Inducement Plan
Two Thousand Twenty Six Inducement Plan [Member]
Two thousand twenty six inducement plan.
Summary of Expected Future Amortization Expense for Finite-lived Intangible Assets
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Other Nonoperating Income (Expense) [Abstract]
Other income/(expense):
MindMed stock option plan.
Mind Med Stock Option Plan [Member]
MindMed Stock Option Plan
Expired, shares
Warrants expired.
Warrants Expired
Pre-Funded Warrants [Member]
Pre-Funded Warrants.
Pre Funded Warrants
Lender Name [Axis]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Estimated Fair Value, Total
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
Employee Stock [Member]
Estimated ESPP awards
Estimated ESPP shares
Entity Registrant Name
Entity Registrant Name
Credit Facility
Debt Disclosure [Text Block]
Unrealized Losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Other Nonoperating Income (Expense)
Total other income/(expense), net
Total other income/(expense)
Subsequent Events [Abstract]
Measurement Frequency [Axis]
Measurement Frequency
Proceeds from the Offerings and Private Placement
Proceeds From Offerings and Private Placement
Proceeds from the Offerings and Private Placement.
Proceeds from issuance of common shares, net of issuance costs
Net proceeds from common stock
Proceeds from the 2022 ATM net of issuance costs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Schedule of Assumptions used to Determine Fair Value of 2022 USD Financing Warrants
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Change in fair value on directors' deferred share units
Change in fair value on directors' deferred share units.
Change in fair value on directors' deferred share units ("DDSU")
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentration of Credit Risk
Liability Class [Axis]
Percentage Of Increase Or Decrease Of Ownership By Pre-funded Warrants Holder
Percentage of increase or decrease of ownership by pre-funded warrants holder.
Percentage of increase or decrease of ownership by pre-funded warrants holder
Accumulated other comprehensive income
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated Other Comprehensive Income (Loss), Net of Tax
Number of shares, granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost
Available for sale securities debt maturities after one through two years amortized cost.
Amortized Cost, Due in one to two years
Assets
Total assets
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Stock purchase option, exercisable term
Income Statement [Abstract]
Stock-based compensation
Share-Based Payment Arrangement [Policy Text Block]
Sale of Stock, Number of Shares Issued in Transaction
Sale of shares
Stock issued during period
Stock Issued During Period, Shares, New Issues
Issuance of common shares, net of shares issuance cost, Shares
Number of shares, vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Number of shares, vested
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
Diluted
Net loss per common share, diluted
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Summary of Additional Expense Details
City Area Code
City Area Code
Debt Instrument, Fee Amount
Accrued final payment fee
Subsequent tranche term loan.
Subsequent tranche term loan [Member]
Subsequent Tranche Term Loan
Intangible Assets
Change in accounting principle, accounting standards update, early adoption [true false]
Stock Issued During Period, Value, Employee Stock Purchase Plan
Nominal amount of expense in relation to ESPP recognized
Issuance of common shares under employee share purchase plan ("ESPP")
Segment Reporting Information [Line Items]
Stock split conversion ratio
Stockholders' Equity Note, Stock Split, Conversion Ratio
Cash Equivalents
Cash and Cash Equivalents, Policy [Policy Text Block]
Conversion Shares [Member]
Conversion shares.
Conversion Shares
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Goodwill
Impairment of intangible assets
Impairment of Intangible Assets, Finite-Lived
Number of options, vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Number of options, vested and exercisable
Issuance of common shares upon conversion of term loan principal
Stock Issued During Period Value Conversion Of Term Loan Principal
Stock issued during period value conversion of term loan principal.
Nature of operations.
Nature Of Operations [Abstract]
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Cash and cash equivalents, end of period
Cash and cash equivalents, beginning of period
Loss from operations
Operating Income (Loss)
Loss from operations
Accumulated Deficit
Retained Earnings [Member]
Business combination, maximum measurement period.
Business Combination Maximum Measurement Period
Business combination, maximum measurement period
Expected volatility
Measurement Input, Price Volatility [Member]
Payments of Stock Issuance Costs
Payment of share issuance cost
Payment of equity offering costs
Fair Value, Inputs, Level 1 [Member]
Level 1
Class of Stock [Line Items]
Class Of Stock [Line Items]
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash provided by financing activities
Term loan.
Term Loan [Member]
Term Loan
Change in accounting principle, accounting standards update, adopted [true false]
Two Thousand Twenty Two At The Market Offering Program [Member]
Two thousand twenty two at the market offering program.
2022 At-The-Market Facilities
Proceeds from Exercise of Warrants in Prepaid and Other Current Assets
Proceeds from exercise of warrants in prepaid and other current assets.
Proceeds from exercise of 2022 USD Financing Warrants in prepaid and other current assets
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Summary of Outstanding Liability Classified as Warrants
US Government Corporations and Agencies Securities [Member]
U.S. agency bonds
Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share due to Anti-dilutive Effect
Accrued clinical and manufacturing costs.
Accrued clinical trial costs
Entity Interactive Data Current
Entity Interactive Data Current
Statement of Income Location, Balance [Domain]
Income Statement Location
Cash flows from operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Additional Tranche Term Loan
Additional Tranche Term Loan.
Additional Tranche Term Loan [Member]
Repayments of Lines of Credit
Repayment of credit facility
Accretion (Amortization) of Discounts and Premiums, Investments
Accretion of discount on investments, net
Available For Sale Securities Debt Maturities After Two Through Three Years Amortized Cost
Available for sale securities debt maturities after two through three years amortized cost.
Amortized Cost, Due in two to three years
Cash equivalents
Cash Equivalents, at Carrying Value
Cash Equivalents, at Carrying Value, Total
Entity Tax Identification Number
Entity Tax Identification Number
Amortized Cost
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]
Share Price
Share price
Share price
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale
Maturity of investments
Amendment Loan Agreement and Refinance of Loan [Member]
Amendment loan agreement and refinance of loan.
Amendment Loan Agreement and Refinance of Loan
Warrant exercise.
Warrant Exercise
Warrant exercise
Local Phone Number
Local Phone Number
Loan and Security Agreement
Loan and security agreement.
Loan and Security Agreement [Member]
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Unrecognized stock-based compensation expense related to unvested options granted
Payments of Financing Costs, Total
Payments of Financing Costs
Payment of facility fee
Payment of credit facility issuance costs
Accounting Policies [Abstract]
Long-Term Line of Credit, Noncurrent
Credit facility, long-term
General and Administrative Expense [Abstract]
General and administrative:
Class of Stock [Domain]
Class of Stock
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Weighted average period for recognition of unvested options granted
Accrued Professional Fees, Current
Professional services
Stock, Class of Stock [Table]
Schedule Of Stock By Class [Table]
Common stock, shares authorized
Common Stock, Shares Authorized, Unlimited [Fixed List]
Entity Emerging Growth Company
Entity Emerging Growth Company